Cannabis legalization took center stage for a lot of the 2020 political elections. Many Americans have started to accept cannabis as a normal part of life. Instead of being viewed through the eyes of a brainwashed reefer madness past, cannabis is being viewed by eyes peering into the future. Negative stereotypes about this misunderstood plant are being broken down on a regular basis. Negative stigmas attached to the plant and those who consume the plant are also beginning to be dissolved. As time is progressing, more people understand there’s more to cannabis than just smoking it. Cannabinoid therapies open up doors for all sorts of medical potentials, and the commercial and industrial applications of cannabis are virtually endless. The legal cannabis industry would also facilitate a major boost to the economy, creating much-needed jobs in America. These jobs are for more than just those who grow cannabis and sell it. The legal cannabis sector offers employment ranging from IT professionals, legal professionals, accountants, and computer networking specialists all the way to construction workers, plumbers, electricians, and many others. Naturally, more people are welcoming the idea of investing in cannabis.
When it comes to investing in the cannabis sector, many people have been turning to cannabis stocks. Cannabis stocks are considered a risky market still because of current federal regulations that make cannabis illegal. With that in mind, if you have what it takes to risk investing in the cannabis sector while it is being cultivated, then it could pay off.
Under President Donald Trump, the United States of America Federal government showed no signs of ending decades-old cannabis prohibition. On November 3rd, all that might have just changed. Many people say that having Joe Biden as our new president is a win for the legal cannabis industry. With the news of Joe Biden winning the presidency, cannabis stocks saw a great increase and surged by 10% to 20% on average. Tilray, Aurora Cannabis, and Canopy Growth all saw a surge in stock prices. They weren’t the only ones, though. Aphria, Curaleaf, and Cronos also rallied a strong start the week after the election.
The CEO of Canopy, David Klein, was quoted telling analysts;
“We believe the Biden win is an important step on the path to Federal permissibility of cannabis in the US market through decriminalization and descheduling. The results of the ballot initiatives clearly showcase that support for adult-use marijuana legalization extends across geographic and party lines and is supported by a majority of Americans. Legal marijuana is becoming the American Norm. This will likely increase pressure on Congress to pass major federal marijuana reform in the very near future.”
The growth of stocks and their surge not only shows money being made it also shows demand. Demand for cannabis stocks means the demand for cannabis. This demand is driven by the American people. It just goes to show you when politicians are looking for money, suddenly billions of dollars of claimable income from cannabis tax revenue start to sound pretty good to them.
Cannabis legalization on a federal level not only helps stocks surge, but it would also pave the path for the United States to jump into a budding global cannabis trade. Israel and Canada, along with Spain, are already participating in a global cannabis trade market that the United States is currently missing out on.
David Klein was not alone in expressing viewpoints supporting positive cannabis reform on a federal level in the not too distant future. The same viewpoint was shared by Miguel Martin, who is the CEO of Aurora Cannabis. Martin said, “What we see both in the US and globally is an increasing sort of openness towards THC-bearing cannabinoids and that body’s well for a company like Aurora.”
After some previous challenges, Canopy Growth saw its stock rise by 10% on Monday, November 9th, and is currently sitting at +14.98% YTD. Tilray also was up 10% at the closing bell on the same data. At this time Aurora Cannabis saw their stocks jump up by 20%.
Cannabis stocks are still considered a very risky market. They could fluctuate down as quickly as they go up. If you have the money to play with investing in cannabis stocks, then you may just want to dive in and see if you can make a little green. Many people believe that Federal cannabis legalization stands a better chance this year than at any other time in our history. The US federal government will be voting to legalize cannabis come this December when they discuss the MORE Act.
With more states passing cannabis laws bringing the total number of states in America with some form of medical cannabis access to 36 plus our nation’s capital Washington D.C., it’s only a matter of time before the federal government has to catch up to modern civilization. Investing in cannabis stocks now could be just the risk you need to take to help lay down the foundation for future generational wealth.
I’m all for legalizing like tobacco, So many positive reasons. Medical, and recreational.
I’m 61 , been smoking since 1972. Finally got a medical card…life is good.
President Biden signed off on multiple federal cannabis reforms, a Republican Congresswoman is rallying GOP support for cannabis, and Indiana Democrats are attempting to spark their state’s cannabis legalization efforts. Let’s dive into this week’s cannanews. Biden Signs Infrastructure Bill With Multiple Cannabis Provisions On Monday, President Joe Biden signed a $1 trillion bipartisan infrastructure…
Uber Eats, an online food ordering service, just launched a partnership with a chain of dispensaries in Ontario, Canada called Tokyo Smoke. Starting Monday, Ontario residents of legal age can order cannabis from Tokyo Smoke online using the Uber Eats platform. Tokyo Smoke’s products can now be found under a new section of the Uber…
Recent analysis has shown that for many people, cannabis feels less potent when they are on their period. Why might this be? For many menstruating people, we often find that our “flow” has been shrouded in mystery throughout our lives. From conversations with other menstruating people, as well as my own personal experience, I know…
Have you ever wondered who spends more on cannabis: those who consume recreationally or for medicinal purposes? Well, we’ve got answers. Headset, a leading cannabis data and market intelligence platform, recently conducted an audit of cannabis sales data around the United States—and the discoveries were interesting. Established Med Markets Bring in the Dough As it…
Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies. For the first time in over 50 years, a federal grant…
A brand new study featured in the journal Drug and Alcohol Dependence delivered exciting news to psychiatrists, health professionals, and law enforcement…
One of the most basic sets of terminology in the world of medical and recreational cannabis is that of cannabis weights. However,…
Veriheal does not support illegally consuming therapeutic substances such as psychedelics but acknowledges that it transpires because of the current illicit status,…
